274 related articles for article (PubMed ID: 18159071)
41. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
42. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
43. Follow-up care of patients with breast cancer.
Tolaney SM; Winer EP
Breast; 2007 Dec; 16 Suppl 2():S45-50. PubMed ID: 17697780
[TBL] [Abstract][Full Text] [Related]
44. The significance of signet ring cells in infiltrating lobular carcinoma of the breast.
Frost AR; Terahata S; Yeh IT; Siegel RS; Overmoyer B; Silverberg SG
Arch Pathol Lab Med; 1995 Jan; 119(1):64-8. PubMed ID: 7802556
[TBL] [Abstract][Full Text] [Related]
45. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis.
Lu WL; Jansen L; Post WJ; Bonnema J; Van de Velde JC; De Bock GH
Breast Cancer Res Treat; 2009 Apr; 114(3):403-12. PubMed ID: 18421576
[TBL] [Abstract][Full Text] [Related]
46. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
[TBL] [Abstract][Full Text] [Related]
47. Primary tumor location impacts breast cancer survival.
Sohn VY; Arthurs ZM; Sebesta JA; Brown TA
Am J Surg; 2008 May; 195(5):641-4. PubMed ID: 18424280
[TBL] [Abstract][Full Text] [Related]
48. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution.
Orvieto E; Maiorano E; Bottiglieri L; Maisonneuve P; Rotmensz N; Galimberti V; Luini A; Brenelli F; Gatti G; Viale G
Cancer; 2008 Oct; 113(7):1511-20. PubMed ID: 18704988
[TBL] [Abstract][Full Text] [Related]
50. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
51. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.
Smith TE; Lee D; Turner BC; Carter D; Haffty BG
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1281-9. PubMed ID: 11121624
[TBL] [Abstract][Full Text] [Related]
52. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.
Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H
Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816
[TBL] [Abstract][Full Text] [Related]
53. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
54. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
55. Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
Webster LR; Lee SF; Ringland C; Morey AL; Hanby AM; Morgan G; Byth K; Mote PA; Provan PJ; Ellis IO; Green AR; Lamoury G; Ravdin P; Clarke CL; Ward RL; Balleine RL; Hawkins NJ
Clin Cancer Res; 2008 Oct; 14(20):6625-33. PubMed ID: 18927304
[TBL] [Abstract][Full Text] [Related]
56. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
[TBL] [Abstract][Full Text] [Related]
57. Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?
Zakaria S; Pantvaidya G; Reynolds CA; Grant CS; Sterioff S; Donohue JH; Farley DR; Hoskin TL; Degnim AC
Surgery; 2008 May; 143(5):641-7. PubMed ID: 18436012
[TBL] [Abstract][Full Text] [Related]
58. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
[TBL] [Abstract][Full Text] [Related]
59. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS
Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634
[TBL] [Abstract][Full Text] [Related]
60. Ipsilateral breast tumor recurrence after breast-conserving therapy.
Panet-Raymond V; Truong PT; Watson PH
Expert Rev Anticancer Ther; 2010 Aug; 10(8):1229-38. PubMed ID: 20735309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
